Medically reviewed by Dr Sin Yong · Last reviewed · 14 min read · Doctor-performed, never delegated · Jump to questions
Dr Sin Yong · MBBS (NUS) · MRCS (Edin) · MSc Aesthetic Medicine with Distinction (Queen Mary, London) · MSc Practical Dermatology (Cardiff) · International KOL
Exosomes are the most talked-about ingredient in regenerative aesthetics — and one of the least accurately described. In Singapore they are applied topically, most usefully in the window after laser or microneedling opens the skin. This page explains what they are, where the evidence stands, what HSA regulation means for how they can be used here, and when a different regenerative option serves you better.
Exosome therapy in Singapore uses exosomes, nano-sized extracellular vesicles of roughly 30 to 150 nanometres that cells release as messengers, applied topically after laser or microneedling. HSA regulation shapes how they can be used here, so Dr Sin Yong explains the source, the evidence and its limits.
Exosomes are nano-sized extracellular vesicles — roughly 30 to 150 nanometres — released by cells as messengers. They carry growth factors, lipids and nucleic acids that influence how nearby cells behave: dialling inflammation down, nudging fibroblasts toward collagen production, supporting repair. Aesthetic products use exosomes derived from sources such as stem-cell culture or plant tissue. They are signalling cargo, not living cells — and that distinction is what makes them usable topically.
In Singapore, exosome products are used topically — applied to skin, ideally when a procedure such as fractional CO2, microneedling or RF microneedling has just created channels for them to reach living skin layers. Injecting exosomes is a different regulatory category and is not part of practice here. Any clinic marketing “topical exosome application” in Singapore should prompt questions, not bookings. Used honestly — as a post-procedure recovery and skin-quality adjunct — the early clinical literature is genuinely promising, and it is cited at the bottom of this page.
On intact skin, most large molecules sit on the surface — the stratum corneum is a barrier by design. This is why the meaningful use of exosomes is procedure-paired: immediately after fractional laser resurfacing (such as pico fractional or Tetra Pro CO2) or microneedling, when thousands of microchannels are open, topically applied exosomes can reach the epidermis and superficial dermis where their signalling is relevant.
Used in that window, published human studies and systematic reviews report faster visible recovery — less redness and downtime after energy-based procedures — and improvements in skin texture and quality over the following weeks. The literature is early: studies are small, products vary widely, and exosomes are an adjunct to a well-chosen procedure, not a replacement for one. That is the accurate version of the trend.
The clearest use: applied immediately after CO2 or pico fractional resurfacing to support recovery in the open-channel window. Paired naturally with acne scar resurfacing.
Microchannels created by RF microneedling serve the same delivery purpose at lower intensity — a skin-quality pairing for texture and pores.
Topical exosome preparations are also used on the scalp alongside energy-based hair protocols — an adjunct within regenerative hair restoration, not a standalone cure.
Exosome injections are not part of aesthetic practice in Singapore. Anything sold to you as an exosome “jab” deserves scrutiny of exactly what is in the syringe.
Injectable regenerative treatments with established registration — Rejuran (polynucleotides), Profhilo, skin boosters — remain the injectable route; exosomes complement them topically.
Exosome products vary enormously in source, concentration and stability. Which product, if any, is used on your skin is a medical decision made openly at consultation.
“Exosomes are messengers, not miracles. On intact skin they sit on the surface — the procedure opens the door, the exosomes walk through it.”Dr Sin Yong
References: Clinical Evidence and Commercial Landscape of Topical Exosomes for Skin Rejuvenation: A Scoping Review (Knauer et al., 2026) · Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies (Flores Rodríguez et al., 2026) · Extracellular Vesicles in Regenerative and Cosmetic Medicine: Safety, Clinical Effectiveness and Translation (Contreras & Ariza-Donado, 2026)
Your actual concern — texture, pores, post-inflammatory change, recovery speed, scalp — is assessed first. Exosomes are proposed only where the pairing makes sense.
The delivery procedure is chosen for your skin (fractional laser, pico, or RF microneedling), with exosomes as the post-procedure application in the open-channel window.
“Exosome describes a particle, not what is in a particular vial; the source and preparation are what matter.”
Dr Sin YongOn exosome products
Applied immediately post-procedure with a recovery protocol. Products used are named openly — you are told exactly what is on your skin.
Skin quality and recovery are reviewed against baseline photographs, and the plan is adjusted — including dropping the adjunct if it is not earning its place.
| Option | What it does | What it cannot do | What to expect afterwards | Who it tends to suit |
|---|---|---|---|---|
| Topical exosomes after a procedure | Applied just after fractional laser or microneedling, while the skin's channels are open. | An adjunct, not a replacement; evidence is early, with small trials and varied products. | Recovery follows the underlying procedure; products are named openly. | Skin already being treated with fractional laser or RF microneedling. |
| Registered injectables (Rejuran, Profhilo, skin boosters) | The established injectable route for regenerative skin treatment, with registration. | Exosomes are a different category; these do not work as topical adjuncts. | Discussed at consultation, once the area and plan are assessed. | Those wanting an injectable regenerative option. |
| Fractional laser or microneedling alone | Treats skin quality through the procedure itself. | Does not add the signalling cargo exosomes are proposed to carry. | Recovery follows the procedure; discussed at consultation. | Those preferring a procedure without an adjunct. |
| Exosome injection | Proposed to deliver signals into skin; evidence is limited. | No HSA-approved injectable exosome product; it is not part of practice here. | Registered injectables are discussed instead. | Not recommended; ask what is in any syringe sold as an exosome jab. |
| Over-the-counter exosome serum | Applied at home to intact skin. | Large vesicles largely stay on the surface, so procedure-paired delivery cannot be replicated. | An everyday routine with no procedural recovery. | Those wanting a home product, with modest expectations. |
| Topical scalp exosomes in a hair plan | Used on the scalp alongside energy-based stimulation and medical therapy. | Not a standalone cure for androgenetic hair loss; evidence is early. | Discussed at consultation, once the area and plan are assessed. | Hair concerns managed within a proper hair protocol. |
People who expect a stand-alone treatment, an injectable or a cure for hair loss from exosomes tend to be disappointed, because they are an adjunct to a procedure.
Redness, warmth and mild irritation follow the paired procedure itself, and the exosome product is applied into the same open channels. Less commonly, a contact or allergic reaction, a flare of an existing skin condition or an infection can occur. Exosome products vary widely in source, concentration and stability, and the published studies are small, so the effect of the adjunct cannot be separated reliably from the effect of the procedure. This is why the product is named openly and the adjunct can be dropped if it is not earning its place.
The fee depends on the delivery procedure chosen (fractional laser, pico or RF microneedling), the area treated, the exosome product used, and whether it is part of a hair or scalp plan. Because exosomes are an adjunct to a procedure, the quote covers both together. A written quote is given at consultation after assessment, with the product named. The consultation also decides whether an exosome adjunct is advised at all, or whether the procedure alone is more sensible.
How quotes work at this practice: how we quote.
Exosomes are used topically here, and injection is a different regulatory category that is not part of practice.
On intact skin large vesicles largely stay on the surface, which is why delivery is paired with a procedure that opens channels.
Exosomes are nano-sized extracellular vesicles that cells use as messengers, carrying growth factors and nucleic acids that influence repair and collagen activity. In aesthetics they are applied topically — most usefully right after a procedure has opened microchannels in the skin.
No — in Singapore exosomes are used topically. Injectable use is a different regulatory category and is not part of practice here. If something is being sold to you as an exosome injection, ask precisely what is in the syringe and under what registration.
The phrase usually refers to a topical exosome application layered over microneedling or laser — using the procedure's microchannels for delivery. It is different from injectable skin boosters such as Rejuran or Profhilo, which are registered injectables.
Used in the post-procedure window, published human studies report faster visible recovery and skin-quality improvements. The evidence base is early — small trials and highly variable products — which is why they are framed here as an adjunct, not a standalone treatment.
Different tools. Rejuran is an injectable polynucleotide with established registration and delivery into the skin; exosomes here are topical signalling adjuncts after procedures. They are complementary rather than competing, and the choice depends on your skin and goals.
Post-fractional recovery support is their clearest use: applied when the channels are open, they are associated with less downtime and smoother recovery. The scar result itself still comes from the resurfacing and subcision plan, not the serum.
Topical scalp exosomes are used as an adjunct within a proper hair protocol — alongside energy-based stimulation and medical therapy. Evidence is early; they are not a standalone cure for androgenetic hair loss.
Commercial products derive exosomes from sources such as stem-cell culture media (human or animal) or plant tissue, then purify and stabilise them. Source, concentration and stability vary widely between brands — one reason product choice is a medical decision.
Applied topically in clinic, reported adverse events in the published literature are low and generally mild. The meaningful safety questions are product quality and honest use — both of which are addressed openly at consultation.
It depends on the underlying procedure plan the exosomes are paired with — recovery support may be single-session; skin-quality programmes are staged. Numbers before assessment would be guesswork.
Over-the-counter “exosome” cosmetics exist, but on intact skin large vesicles largely stay on the surface — the barrier works. The clinical logic depends on procedure-paired delivery, which is not replicable at home.
It depends on the procedure it is paired with and the programme structure. Costs are set out transparently at consultation, before anything is decided.
The fee depends on the delivery procedure (fractional laser, pico or RF microneedling), the area treated and the exosome product, because the adjunct is applied together with a procedure. A written quote is given at consultation after assessment with the product named, and the consultation also decides whether an exosome adjunct is advised at all.
It may be worth considering if you are already having fractional laser or microneedling and accept that the evidence is early, with small studies and varied products. It is the wrong tool if you expect an injectable, a stand-alone treatment or a cure for hair loss. The procedure remains the main driver.
No duration can be promised. The exosomes are applied once as part of a procedure, so what you notice depends mainly on the procedure, your skin, product quality, sun protection and skincare afterwards. Early studies cannot yet give reliable longevity. Review timing is set at consultation against your baseline photographs.
Evidence is early, with small trials and products that differ widely in source and stability. Injection is not part of practice here, and on intact skin large vesicles largely stay on the surface. It adds cost to a procedure, an allergic or irritant reaction can occur, and its benefit is hard to separate from the procedure.
Question not answered here? Ask on WhatsApp, use the enquiry form, or browse 100 questions patients ask.
Medically reviewed by Dr Sin Yong, MBBS (NUS), MRCS (Edinburgh) · Last updated 7 October 2026 · Editorial policy
Start with a message, not an appointment. Describe your skin concern on WhatsApp and you will get a straightforward reply about whether exosome pairing — or a better-evidenced alternative — makes sense for you.
Replies within clinic hours: Mon–Fri 10am–8pm, Sat 11am–3pm · How consultations work · Prefer not to use WhatsApp? · Treatment finder
WhatsApp +65 8023 7170This page is general information, not a diagnosis. Suitability for any treatment is decided at an in-person medical assessment.
1. Flores Rodríguez JC, Toledo Avelar LE, Yi K, et al. Efficacy of Exosome-Based Therapies for Skin Rejuvenation: A Systematic Review of Human Studies. Cureus 2026;18(2):e104182. PubMed